Publications

Project

C-Reactive Protein as a Prognostic Marker After Lacunar Stroke: Levels of Inflammatory Markers in the Treatment of Stroke Study

Elkind MS, Luna JM, McClure LA, Zhang Y, Coffey CS, Roldan A, Del Brutto O, Pretell EJ, Pettigrew LC, Meyer BC, Tapia J, White C, and Benavente OR on behalf of the LIMITS Investigators

Stroke. 2014; 45 (3) 707-716.

PubMed:

PMC4114338

Designing Clinical Trials for Dystonia

Galpern WR, Coffey CS, Albanese A, Cheung K, Comella CL, Ecklund DJ, Fahn S, Jankovic J, Kieburtz K, Lang AE, McDermott MP, Shefner JM, Teller JK, Thompson JLP, Yeatts SD, and Jinnah HA

Neurotherapeutics. 2014; 11 (1) 117-127.

PubMed:

PMC3899487

Physician-Pharmacist Collaborative Management of Asthma in Primary Care

Gums TH, Carter BL, Milavetz G, Buys L, Rosenkrans K, Uribe L, Coffey C, MacLaughlin EJ, Young RB, Ables AZ, Patel-Shori N, and Wisniewski A

Pharmacotherapy. 2014; 34 (10) 1033-1042.

PubMed:

PMC4188693

Predictors of Mortality in Patients with Lacunar Stroke in the Secondary Prevention of Small Subcortical Strokes Trial

Sharma M, Pearce LA, Benavente OR, Anderson DC, Connolly SJ, Palacio S, Coffey CS, and Hart RG

Stroke. 2014; 45 (10) 2989-2994.

PubMed:

PMC4175186

Effects of bracing in adolescents with idiopathic scoliosis

Weinstein SL, Dolan LA, Wright JG, Dobbs MB.

New England Journal of Medicine. 2013 Oct; 369 (16) 1512-21.

PubMed:

24047455

Surgical results of the Carotic Occlusion Surgery Study

Grubb RL Jr, Powers WJ, Clarke WR, Videen TO, Adams HP Jr, Derdeyn CP, Carotic Occlusion Study Investigators.

Journal of Neurosurgery. 2013 Jan.; 118 (1) 25-33.

PubMed:

PMC4246998

Clinical Features and Racial/Ethnic Differences among the 3020 Participants in the Secondary Prevention of Small Subcortical Strokes (SPS3) Trial

White CL, Szychowski JM, Roldan A, Benavente MF, Pretell EJ, Del Brutto OH, Kase CS, Arauz A, Meyer BC, Meissner I, Demaerschalk BM, McClure LA, Coffey CS, Pearce LA, Conwit R, Irby LH, Peri K, Pergola PE, Hart RG, and Benavente OR for the SPS3 Investigators

Journal of Stroke and Cerebrovascular Diseases. 2013 Aug; 22 (6) 764-774.

PubMed:

PMC3970545

Association of Cerebrospinal Fluid Aβ1-42, t-tau, p-tau181, and α-synuclein Levels with Clinical Features of Early Drug Naïve Parkinson’s Disease Patients

Kang JH, Irwin DJ, Chen-Plotkin AS, Siderowf A, Caspell C, Coffey CS, Waligorska T, Taylor P, Pan S, Frasier M, Marek K, Kieburtz K, Jennings D, Simuni T, Tanner CM, Singleton A, Toga AW, Chowdhury S, Mollenhauer B, Trojanowski JQ, Shaw LM and the Parkinson’s Progression Marker Initiative Investigators

Archives of Neurology. 2013; 70 (10) 1277-1287.

PubMed:

PMC4034348